The global Progressive Supranuclear Palsy Treatment market accounted for US$ 51.1 billion in 2020 and is estimated to be US$ 24.0 billion by 2029 and is anticipated to register a CAGR of 5.3%.

The report "Global Progressive Supranuclear Palsy Treatment Market, By Drug Type (Dopamine, Anticholinergic Agents, Tricyclic Antidepressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

In September 2019, UCB S.A., a global biopharmaceutical company based in Belgium focusing on the discovery and development of innovative medicines and solutions, released a new data for UCB0107, an anti-Tau immunotherapy Phase I study results at World Movement Disorders Conference, France. UCB0107 is a recombinant, humanized, full-length IgG4 monoclonal antibody, a potential treatment for patients with progressive supranuclear palsy (PSP).
In February 2019, AlzProtect, a biopharmaceutical company engaged in the development of drugs announced about its successful completion of the latest phase 1 study about the effect of food intake for its drug candidate AZP2006. AZP2006 (EZEPROGIND), is a bioavailable neurotrophic inducer, targeting causes of neurodegeneration diseases.
Analyst View:

Rising incidences of progressive Supranuclear palsy

The rising incidences of progressive Supranuclear palsy worldwide are a key factor aiding in expansion of the global progressive Supranuclear palsy treatment market. Progressive Supranuclear palsy paralysis, also known as Steele-Richardson-Olszewski condition, is an unprecedented mind issue that causes major issues with strolling, equilibrium and eye developments. The problem results from disintegration of cells in zones of your cerebrum that control body development and thinking. Reformist supranuclear paralysis deteriorates over the long haul and can prompt perilous difficulties, like, pneumonia and gulping issues. For instance, according to the National Center for Biotechnology Information (NCBI), an article published in July 2020, reports that globally the prevalence of progressive supranuclear palsy is 5.8 to 6.5 per 100,000 persons, and the annual incidence rate ranges from 0.3 to 0.4 per 100,000 persons.

Increasing focus on research and development

The major market players are actively focusing on research and development for progressive supranuclear palsy treatment for cost effective and quality treatment. For instance, in July 2018, Asceneuron, a Switzerland-based biotechnology company received orphan drug designation, for its lead drug ASN120290 from the U.S. Food and Drug Administration (FDA). ASN120290’s therapeutic potential has been demonstrated in pre-clinical studies, indicated for the treatment of rare neurodegenerative disease, progressive supranuclear palsy (PSP). However, the lack of knowledge and inadequate research and development for treatment is expected to hinder the market growth. The ongoing clinical trials are lacking in identification of disease-modifying therapies often targeting the underlying tau pathology.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Progressive Supranuclear Palsy Treatment Market”, By Drug Type (Dopamine, Anticholinergic Agents, Tricyclic Antidepressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029

Key Market Insights from the report:

The global progressive supranuclear palsy treatment market accounted for US$ 51.1 billion in 2020 and is estimated to be US$ 24.0 billion by 2029 and is anticipated to register a CAGR of 5.3. The market report has been segmented on the basis of drug type, distribution channel, and region.

Depending upon drug type, the dopamine segment is projected to grow at highest CAGR over the forecast period owing to its effective indication for the prevention and treatment.
Depending upon distribution channel, the hospital pharmacies segment is projected to grow at highest CAGR over the forecast period as partnerships and agreements of hospitals with specialty pharmacies services providers are expected to drive the segment growth during the forecast period.
By region, The North America progressive supranuclear palsy (PSP) market has been growing at a tremendous pace in recent times. The presence of a seamless sector for neural research in the US and Canada has created new avenues for market growth across the region. Besides, the presence of state-of-the-art technologies for brain cell study in the region has also aided market expansion.
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Progressive-Supranuclear-Palsy-Treatment-Market-4544

Competitive Landscape:

The prominent player operating in the global progressive supranuclear palsy treatment market includes AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., UCB Biopharma, AlzProtect, Asceneuron Therapeutics, TauRx Pharmaceuticals, GlaxoSmithKline PLC, Novartis AG, and Teva Pharmaceutical Industries Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis
Investment Analysis
Competitive Analysis
To know more

Contact Us:

Sales

Prophecy Market Insights

Email- This email address is being protected from spambots. You need JavaScript enabled to view it.

Mental Health Action Day is an open-source movement of brands, organizations and cultural leaders to drive culture from mental health awareness to mental health action. The first Mental Health Action Day will take place on May 20, 2021 with a mission to encourage and empower people to take their first steps towards mental health action -- whether for themselves, for their loved ones or to advocate for systemic changes, because mental health is health.

Denton, Texas, United States., April 24, 2021 -- First National ‘Mental Health Action Day’ to Drive People to Take a First Mental Health Action for Themselves or Others

One year into COVID-19 and amidst a most dire mental health crisis, ABUNDANCE OF HOPE COUNSELING and nearly 200 organizations team up to plan inaugural ‘Mental Health Action Day’ on May 20.

DALLAS – FORT WORTH, TEXAS -- ABUNDANCE OF HOPE COUNSELING in partnership with 193 leading brands, nonprofits and cultural leaders today announced the first-ever Mental Health Action Day, to be held on Thursday, May 20 during Mental Health Awareness Month. Over the past two decades, suicide rates have risen, particularly among young adults. And the COVID pandemic has accelerated the already dire crisis, giving way to what many mental health professionals have called the “second pandemic.”

Though more people than ever are comfortable discussing mental health, finding effective resources and knowing how to get help remains a challenge. Mental Health Action Day is an open-source movement of brands, organizations and cultural leaders to drive culture from mental health awareness to mental health action.

Partners will encourage people to take their first steps towards mental health action -- whether for themselves, for their loved ones or to advocate for systemic changes. Resources and tools will be available for people to seek help in a myriad of ways from starting a meditation practice, learning how to support a friend, or advocating for change.

Learn more at www.MentalHealthActionDay.org

“From Covid-19 to economic struggles and the continuing fight for racial justice, the other half of the twin pandemic is the rise of our mental health challenges,” said Erika Soto Lamb, Vice President of Social Impact Strategy at MTV Entertainment Group. “This is a critical moment to shift our culture from mental health awareness to mental health action and MTV is proud to come together with diverse cross-sector leaders on this inaugural day to encourage and empower people to take action -- for themselves, for their loved ones or for the systemic changes needed to improve our social and emotional wellbeing.”

Chikeitha Owens, owner of Abundance of Hope Counseling has worked diligently educating, advocating and bringing awareness to mental health not only in individual settings but speaking at events as well.

Mental Health Action Day is being planned in partnership with TaskForce, a cultural organizing agency that builds capacity for those taking on the most pressing challenges facing the communities, the nation and the world.

Additional participants and more information about how each partner will activate on May 20 will be forthcoming. More on Mental Health Action Day and initial partners can be found at www.MentalHealthActionDay.org

About Mental Health Action Day:
Mental Health Action Day is an open-source movement of brands, organizations and cultural leaders to drive culture from mental health awareness to mental health action. The first Mental Health Action Day will take place on May 20, 2021 with a mission to encourage and empower people to take their first steps towards mental health action -- whether for themselves, for their loved ones or to advocate for systemic changes, because mental health is health. Learn more at www.MentalHealthActionDay.org

About Abundance of Hope Counseling:
Abundance of Hope Counseling provides virtual mental health counseling in Texas and New Jersey. Provides education and awareness speaking on many platforms breaking the negative stigma associated with mental health. Helping individuals find an abundance of hope in their search for a more abundant life. Abundance of Hope Counseling was founded in 2009 by Chikeitha Owens LPC. Abundance of Hope Counseling services individuals, couples and teens that are seeking change. Abundance of Hope mission statement is to help individuals find an abundance of hope in their search for a more abundant life.

Contact:
Chikeitha Owens LPC
Abundance of Hope Counseling
3001 FM 2181
Ste 100 Corinth, Texas 76210
2147830758
This email address is being protected from spambots. You need JavaScript enabled to view it.
http://www.abundanceofhope.com

It’s hard to go about our daily routine if dealing with pain and impaired bodily movements. We’re slower, stressed, and less inclined to explore new things because of our limited capacity to move about.

Physiotherapy and osteopathy are effective in alleviating pain and restoring our normal bodily functions hampered by injuries, ailments, and other conditions. In the UK, physiotherapy Medway and osteopathy Medway sessions can be easily booked online. These professionals can assist you in getting back to your daily activities.

Here are 11 good reasons to see a physiotherapist or an osteopath today.

1. If you were injured while playing sports

Physiotherapy Medway is effective in helping people recover from sports injuries like sprains and fractures. It can improve a person’s healing process and assist in helping a person regain his strength to play again.

2. Injuries from accidents

Accidents can also cause injuries. People may suffer from whiplash during a motor incident or a frozen shoulder due to a sudden strong tug on the arm. Physiotherapy Medway can help relieve pain and restore your body movement back to normal.

3. During and after pregnancy

Some women may have difficulty moving and adjusting to the changes in her body after giving birth. Osteopathy Medway can help women during their pregnancy, while physiotherapy can help new mums regain their strength.

4. General well-being

Keeping a regular physiotherapy Medway session can benefit your body in the long run. You gain flexibility through stretching, and your body could be more stable because you can balance yourself more. You can also improve your strength through exercises they will prescribe.

5. Helps with ailments

Physiotherapy is also beneficial for people suffering from ailments. Therapy can alleviate pain for arthritis, while exercise helps stabilize a diabetic person’s blood sugar levels. On the other hand, osteopathy Medway is helpful for people with respiratory problems.

6. Provides relief during ongoing treatments

Our bodies undergo changes and experience pain during medical treatments like chemotherapy. Physiotherapy can help patients deal with the swelling that they experience after undergoing chemo sessions.

7. Care after surgery

Not all people feel normal as soon as they come home from a major surgery. Depending on the post-op rehabilitation you will need, physiotherapy or osteopathy might be beneficial to you.

8. Dealing with weight

If you’re still struggling with weight issues despite trying several diets, you may want to consult with a physiotherapist instead. They can help you develop a weight loss regimen that is unique to your lifestyle and body condition.

9. Old age

Seniors can use physiotherapy to deal better with conditions that occur naturally as they get older, like osteoporosis and arthritis.

10. Vertigo and dizziness

Vertigo attacks can happen anytime and render people unable to function momentarily. Therapy can help with this condition that is related to inner ear issues.

11. It is non-invasive and drug-free

Physiotherapy and osteopathy are both non-invasive remedies that are perfectly safe for patients. It is also a good treatment that doesn’t involve drugs.

Hempstead Therapy Center provides excellent care for people dealing with pain caused by various reasons. Whether it’s due to an injury, an ailment or a condition, we’re here to set you on the path to recovery and wellness. You can visit us at The Hempstead Valley Shopping Centre or call us at 01634 393113. Our website is https://hempsteadtherapycentre.co.uk.

The report "Global Duchenne Muscular Dystrophy Treatment Market By Therapeutic Approach and Treatment (Molecular-based Therapies (Mutation Suppression, and Exon Skipping), Steroid Therapy (Corticosteroids), Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Other Therapeutic Approaches and Treatment End Users), By End User (Hospitals/Clinics, Ambulatory Centers, and Other End Users), and Region - Global Forecast to 2029" Global Duchenne Muscular Dystrophy Treatment market is projected to grow from US $xx billion in 2019 to US$ XX billion by 2029. The rising burden of Duchenne muscular dystrophy (DMD) disease is the major factor driving the growth for the target market. The increasing prevalence of chronic diseases, such as cardiovascular and neurovascular diseases, and arthritis are the major factor boosting the growth for the target market. However, factor such as changing government regulations and norms restrain market growth.

Key Highlights:

• In April 2019 FibroGen a leading biopharmaceutical company receives orphan drug designation from the U.S. FDA for pamrevlumab for the treatment of Duchenne muscular dystrophy.

Key Market Insights from the report:        

The global Duchenne Muscular Dystrophy Treatment market accounted for US$ XX billion in 2019 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented on the basis, By Therapeutic Approach and Treatment Type, End-User, and by a region.

• By Therapeutic Approach and Treatment Type global Duchenne Muscular Dystrophy Treatment market is classified into molecular-based therapies (mutation suppression, and exon skipping), steroid therapy (corticosteroids), nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic approaches and treatment end users.
• By End-User global Duchenne Muscular Dystrophy Treatment, the market is classified into hospitals/clinics, ambulatory centres, and other end users.
• By region, The Asia Pacific market is expected to show the highest CAGR owing to growing awareness about Duchenne muscular dystrophy and growing public and private health care insurance coverage. North America is expected to domination the market. Owing to product innovations, great healthcare expenditure, and support of government awareness programs.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Duchenne Muscular Dystrophy Treatment Market By Therapeutic Approach and Treatment (Molecular-based Therapies (Mutation Suppression, and Exon Skipping), Steroid Therapy (Corticosteroids), Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Other Therapeutic Approaches and Treatment End Users), By End User (Hospitals/Clinics, Ambulatory Centers, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2029

To know the upcoming trends and insights prevalent in this market, click the link below:

Links: https://prophecymarketinsights.com/market_insight/Global-Duchenne-Muscular-Dystrophy-Treatment-3969

The key players operating the global Duchenne Muscular Dystrophy Treatment market include BioMarin, Bristol-Myers Squibb Company, Fibrogen Inc., Eli Lilly and Company, Nobelpharma Co. Ltd, NS Pharma Inc., Pfizer Inc., PTC Therapeutics, Santhera Pharmaceuticals and Sarepta Therapeutics. The Key players in the market are focusing on mutual understanding. 

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. Also, we help our client to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- This email address is being protected from spambots. You need JavaScript enabled to view it.